📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Loading analysis...
Diamines & Chemicals Forfeits ₹8.79 Cr as 6.37 Lakh Warrants Lapse
Diamines & Chemicals Limited announced that 6,36,988 convertible warrants have lapsed as holders failed to exercise their conversion option by the March 31, 2026 deadline. Consequently, the company has forfeited the initial 25% subscription amount of ₹8.79 crore (₹138 per warrant). Out of the 9,06,390 warrants originally allotted in October 2024 at an issue price of ₹552, only 2,69,402 were converted into equity. Notably, the promoter group chose not to convert 3,23,388 warrants, which represents a significant portion of the lapsed instruments.
Key Highlights
6,36,988 warrants lapsed out of 9,06,390 initially allotted on October 1, 2024.
Company forfeited ₹8.79 crore, representing the 25% upfront payment for the lapsed warrants.
Promoter group failed to convert 3,23,388 warrants, while non-promoters let 3,13,600 warrants lapse.
The conversion price was set at ₹552 per warrant, and only 29.7% of the total issue was converted.
The company misses out on approximately ₹26.37 crore in anticipated capital from the remaining 75% payment.
💼 Action for Investors
Investors should view the promoter's decision not to exercise warrants at ₹552 as a cautious signal regarding the stock's valuation. Monitor the current market price relative to the strike price to understand the lack of conversion interest.
Loading analysis...
Diamines & Chemicals Receives Disclosure Under SEBI SAST Regulations
Diamines & Chemicals Limited has informed the stock exchanges about a disclosure received under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This specific regulation mandates disclosure when there is a change in shareholding exceeding 2% or when a promoter's holding changes. The disclosure was received by the company on March 25 and subsequently reported to the BSE and NSE. Such filings are key indicators of significant shifts in ownership or promoter confidence.
Key Highlights
Company received disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations
Notification submitted to BSE (Scrip Code: 500120) and NSE (Symbol: DIAMINESQ) on March 26, 2025
The disclosure pertains to a transaction or change in holding reported on March 25
Regulation 29(2) filings typically involve transactions by promoters or major institutional investors
💼 Action for Investors
Investors should check the detailed SAST filing on the exchange websites to identify the specific party involved and whether they were buying or selling. Promoter acquisitions are generally viewed as a positive signal of internal confidence.
Loading analysis...
Diamines & Chemicals Converts 2.69 Lakh Warrants into Equity; Raises Rs. 11.15 Crore
Diamines & Chemicals Limited has approved the conversion of 2,69,402 warrants into an equal number of equity shares following the receipt of the 75% balance payment. This exercise has resulted in a capital infusion of approximately Rs. 11.15 crore into the company. The conversion was primarily driven by promoter group entities, including the Mehta family and associated companies, indicating strong promoter commitment. Following this allotment, the company's total paid-up equity capital has increased to Rs. 10.05 crore, with 6,36,988 warrants still pending for future conversion.
Key Highlights
Conversion of 2,69,402 warrants into equity shares at a total issue price of Rs. 552 per share.
Receipt of Rs. 11.15 crore representing the 75% balance exercise price (Rs. 414 per warrant).
Promoter group entities dominated the conversion, including Amit Mehta and S Amit Speciality Chemicals.
Total paid-up equity shares increased from 97,83,990 to 1,00,53,392 shares.
6,36,988 warrants remain outstanding and must be converted within 18 months of their original allotment.
💼 Action for Investors
The conversion of warrants by promoters at a price of Rs. 552 per share reflects management's confidence in the company's long-term prospects. Investors should monitor the utilization of the newly raised capital and the eventual conversion of the remaining warrants.
Loading analysis...
Diamines & Chemicals Q3 FY26: Net Loss Widens to ₹192.55 Lakhs as Revenue Drops 56% YoY
Diamines & Chemicals Limited reported a significant downturn in its Q3 FY26 results, with standalone revenue falling 56.4% YoY to ₹763.57 Lakhs. The company recorded a net loss of ₹192.55 Lakhs for the quarter, a sharp increase from the ₹15.34 Lakhs loss in the previous year's corresponding quarter. For the nine-month period, the company reported a total loss of ₹901.97 Lakhs compared to a profit of ₹287.07 Lakhs in the prior year. The decline is primarily attributed to poor performance in the Specialty Chemicals segment, which saw its segment results turn into a loss.
Key Highlights
Standalone Revenue from Operations fell to ₹763.57 Lakhs in Q3 FY26 from ₹1,751.41 Lakhs in Q3 FY25.
Net loss for the nine months ended Dec 31, 2025, stood at ₹901.97 Lakhs compared to a profit of ₹287.07 Lakhs in the previous year.
Specialty Chemicals segment loss before tax and finance costs was ₹290.20 Lakhs for the quarter.
Total expenses for the quarter were ₹1,139.19 Lakhs, significantly exceeding the total income of ₹835.63 Lakhs.
The company made a provision of ₹4.62 Lakhs towards the impact of new Labour Codes effective from November 2025.
💼 Action for Investors
The sharp decline in revenue and transition to significant losses indicate severe operational headwinds in the specialty chemicals sector. Investors should remain cautious and wait for signs of margin recovery or improved demand before considering any fresh investments.
Loading analysis...
Diamines & Chemicals Reports Q3 FY26 Net Loss of ₹1.93 Cr as Revenue Drops 56% YoY
Diamines & Chemicals Limited reported a significantly weak performance for the quarter ended December 31, 2025, posting a standalone net loss of ₹192.55 Lakhs compared to a profit of ₹157.50 Lakhs in the same quarter last year. Revenue from operations plummeted by over 56% YoY to ₹763.87 Lakhs, reflecting severe pressure in its core Specialty Chemicals segment. For the nine-month period ending December 2025, the company has accumulated a net loss of ₹901.97 Lakhs, a sharp reversal from the ₹287.07 Lakhs profit recorded in the previous year's corresponding period. The board also reviewed and approved a revised Related Party Policy during the meeting.
Key Highlights
Revenue from operations fell 56.4% YoY to ₹763.87 Lakhs in Q3 FY26 from ₹1,751.41 Lakhs in Q3 FY25.
Standalone net loss for the quarter stood at ₹192.55 Lakhs versus a net profit of ₹157.50 Lakhs in the prior year period.
Specialty Chemicals segment recorded a loss of ₹290.20 Lakhs before tax and finance costs during the quarter.
Nine-month (9M FY26) revenue declined to ₹2,917.05 Lakhs from ₹5,349.75 Lakhs in 9M FY25.
The company made a provision of ₹4.62 Lakhs towards the impact of new Labour Codes effective from November 2025.
💼 Action for Investors
The sharp decline in revenue and transition to significant losses indicate serious operational or market headwinds for the company's specialty chemicals business. Investors should remain cautious and wait for signs of margin stabilization or a recovery in demand before considering any fresh positions.
Loading analysis...
Diamines & Chemicals Gets GPCB Approval for Product Mix Amendment to Boost Production Capacity
Diamines & Chemicals Limited has received a Consolidated Consent & Authorization (CC&A) amendment from the Gujarat Pollution Control Board (GPCB) on January 21, 2026. This regulatory approval allows the company to modify its product mix and set up new industrial activities within its existing manufacturing unit in Vadodara. The management expects this move to facilitate the production of new items and contribute to an overall increase in total production capacity. The license is valid until September 30, 2027, providing a clear operational runway for the planned expansion.
Key Highlights
Received CC&A Amendment from Gujarat Pollution Control Board (GPCB) on January 21, 2026
Approval enables setting up of new industrial plant/activities within the existing manufacturing unit
The amendment allows for a revised product mix, leading to an increase in total production capacity
The regulatory license (Order AWH-151692) is valid for a period ending September 30, 2027
💼 Action for Investors
Investors should view this as a positive step toward volume growth and monitor the company's timeline for the commencement of new product manufacturing.